denileukin diftitox - injection, Ontak
GENERIC NAME: DENILEUKIN DIFTITOX - INJECTION (den-ih-LEW-kin DIFF-teh-tox)
BRAND NAME(S): Ontak
WARNING: Unlikely but very serious (possibly fatal) side effects may occur during treatment with denileukin diftitox. Tell your doctor immediately if you have any unusual symptoms during the infusion (see Side Effects section). Also tell your doctor immediately if you experience any of the following symptoms: dizziness, lightheadedness, fainting, sudden weight gain, swelling ankles/feet, or vision changes (e.g., loss of vision/color vision).
USES: Denileukin diftitox is used to treat a certain type of cancer (cutaneous T-cell lymphoma, also known as CTCL) in patients whose cancer keeps returning or in patients who have not responded to other cancer chemotherapy treatment. It works by killing certain blood/cancer cells from your immune system (e.g., B cells, T cells).
Medically Reviewed by a Doctor on 4/16/2014
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index